Sema4 Growth, Revenue, Number of Employees and Funding
- Sema4 has 340 Employees.
- Sema4 grew their employee count by 28% last year.
- Sema4 currently has 62 job openings.
What Is Sema4?
Sema4 is a patient-centered predictive health company and a leader in diagnostic testing. The company is founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease. A Mount Sinai Health System venture based in Stamford, Connecticut, Sema4 is enabling physicians and patients to more seamlessly engage the digital universe of data, from genome test results and clinical records to wearable sensor metrics and more. We currently offer advanced genome-based diagnostics for reproductive health and oncology and are building predictive models of complex disease. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all. At Sema4, we utilize state-of-the-art technologies, and are continuously developing new tests to support patient care. We understand the complexity that comes with navigating the world of genetics and genomicsincluding test ordering, billing, insurance coverage, genetic counseling, and reporting of results and offer services and digital tools to support providers and patients. Learn more at sema4.com -The Team: Led by Dr. Eric Schadt, a pioneer in big data and systems biology, Sema4's interdisciplinary team of scientists, doctors, engineers, clinicians and genetic counselors are all dedicated to empowering healthier living through data. -What does the name mean Our name is derived from semaphorea device used for sending signals. In this spirit, our team will discern signal from noise across trillions of data points in pursuit of our mission to gain meaningful insights into human health and disease.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Health care testing company Sema4 announced this week it would help launch an asthma study that aims to advance diagnoses and
Sanofi and Sema4 have launched a five-year longitudinal study of nearly 1,200 asthma patients, with plans to incorporate digital tools to
NEW YORK (GenomeWeb) – Sema4 and Mount Sinai Health System have launched a five-year study in collaboration with Sanofi to study